SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000819050-19-000028
Filing Date
2019-11-13
Accepted
2019-11-13 16:10:25
Documents
3
Period of Report
2019-11-13
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a20190930-8ker.htm 8-K 26618
2 EXHIBIT 99.1 a20190930-8kex991.htm EX-99.1 93063
3 logo.jpg GRAPHIC 4821
  Complete submission text file 0000819050-19-000028.txt   127657
Mailing Address 5777 CENTRAL AVENUE SUITE 102 BOULDER CO 80301
Business Address 5777 CENTRAL AVENUE SUITE 102 BOULDER CO 80301 (720) 505-4755
Brickell Biotech, Inc. (Filer) CIK: 0000819050 (see all company filings)

IRS No.: 930948554 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-21088 | Film No.: 191214076
SIC: 2836 Biological Products, (No Diagnostic Substances)